{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:06:17Z","timestamp":1793066777899,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":36,"publisher":"Springer US","isbn-type":[{"value":"9781071603185","type":"print"},{"value":"9781071603192","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0319-2_5","type":"book-chapter","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T13:02:45Z","timestamp":1583758965000},"page":"61-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Crotamine Cell-Penetrating Nanocarriers: Cancer-Targeting and Potential Biotechnological and\/or Medical Applications"],"prefix":"10.1007","author":[{"given":"Mirian A. F.","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Darc","family":"Campeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Carvalho","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Szychowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendel Andrade","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo B.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kerkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Karpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.addr.2009.06.001","volume":"61","author":"SB Fonseca","year":"2009","unstructured":"Fonseca SB, Pereira MP, Kelley SO (2009) Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev 61:953\u2013964","journal-title":"Adv Drug Deliv Rev"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1093\/nar\/gkq1299","volume":"39","author":"SEL Andaloussi","year":"2011","unstructured":"Andaloussi SEL, Lehto T, M\u00e4ger I et al (2011) Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vitro. Nucleic Acids Res 39:3972\u20133984","journal-title":"Nucleic Acids Res"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1042\/BST0350767","volume":"35","author":"J Howl","year":"2007","unstructured":"Howl J, Nicholl ID, Jones S (2007) The many futures for cell-penetrating peptides: how soon is now? Biochem Soc Trans 35:767\u2013769","journal-title":"Biochem Soc Trans"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00018-005-5109-0","volume":"62","author":"S Deshayes","year":"2005","unstructured":"Deshayes S, Morris MC, Divita G et al (2005) Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci 62:1839\u20131849","journal-title":"Cell Mol Life Sci"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.addr.2004.10.007","volume":"57","author":"B Gupta","year":"2005","unstructured":"Gupta B, Levchenko TS, Torchilin VP (2005) Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 57:637\u2013651","journal-title":"Adv Drug Deliv Rev"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/ijc.25578","volume":"128","author":"JY Lee","year":"2011","unstructured":"Lee JY, Choi YS, Suh JS et al (2011) Cell penetrating chitosan\/doxorubicin\/TAT conjugates for efficient cancer therapy. Int J Cancer 128:2470\u20132480","journal-title":"Int J Cancer"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.1166\/jnn.2010.2637","volume":"10","author":"BR Liu","year":"2010","unstructured":"Liu BR, Li JF, Lu SW et al (2010) Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides. J Nanosci Nanotechnol 10:6534\u20136543","journal-title":"J Nanosci Nanotechnol"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/978-1-60761-919-2_31","volume":"683","author":"R Sawant","year":"2011","unstructured":"Sawant R, Torchilin V (2011) Intracellular delivery of nanoparticles with CPPs. Methods Mol Biol 683:431\u2013451","journal-title":"Methods Mol Biol"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2174\/138920111796117391","volume":"12","author":"YS Choi","year":"2011","unstructured":"Choi YS, Lee JY, Suh JS et al (2011) Cell penetrating peptides for tumor targeting. Curr Pharm Biotechnol 12:1166\u20131182","journal-title":"Curr Pharm Biotechnol"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/978-1-60761-919-2_38","volume":"683","author":"RM Johnson","year":"2011","unstructured":"Johnson RM, Harrison SD, Maclean D (2011) Therapeutic applications of cell-penetrating peptides. Methods Mol Biol 683:535\u2013551","journal-title":"Methods Mol Biol"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1096\/fj.03-1459fje","volume":"18","author":"A Kerkis","year":"2004","unstructured":"Kerkis A, Kerkis I, Radis-Baptista G et al (2004) Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus. FASEB J 18:1407\u20131409","journal-title":"FASEB J"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/15216540500494508","volume":"58","author":"A Kerkis","year":"2006","unstructured":"Kerkis A, Hayashi MA, Yamane T et al (2006) Properties of cell penetrating peptides (CPPs). IUBMB Life 58:7\u201313","journal-title":"IUBMB Life"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1517\/13543784.2010.534457","volume":"19","author":"I Kerkis","year":"2010","unstructured":"Kerkis I, Silva FS, Pereira A et al (2010) Biological versatility of crotamine - a cationic peptide from the venom of a south American rattlesnake. Expert Opin Investig Drugs 19:1515\u20131525","journal-title":"Expert Opin Investig Drugs"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"21349","DOI":"10.1074\/jbc.M604876200","volume":"282","author":"FD Nascimento","year":"2007","unstructured":"Nascimento FD, Hayashi MA, Kerkis A et al (2007) Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. J Biol Chem 282:21349\u201321360","journal-title":"J Biol Chem"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.toxicon.2008.06.029","volume":"52","author":"MA Hayashi","year":"2008","unstructured":"Hayashi MA, Nascimento FD, Kerkis A et al (2008) Cytotoxic effects of crotamine are mediated through lysosomal membrane permeabilization. Toxicon 52:508\u2013517","journal-title":"Toxicon"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1021\/mp2000605","volume":"9","author":"FD Nascimento","year":"2012","unstructured":"Nascimento FD, Sancey L, Pereira A et al (2012) The natural cell-penetrating peptide crotamine targets tumor tissue in vivo and triggers a lethal calcium-dependent pathway in cultured cells. Mol Pharm 9:211\u2013221","journal-title":"Mol Pharm"},{"issue":"8","key":"5_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006700","volume":"12","author":"SC Lima","year":"2018","unstructured":"Lima SC, Porta LC, Lima \u00c1DC et al (2018) Pharmacological characterization of crotamine effects on mice hind limb paralysis employing both ex vivo and in vivo assays: insights into the involvement of voltage-gated ion channels in the crotamine action on skeletal muscles. PLoS Negl Trop Dis 12(8):e0006700","journal-title":"PLoS Negl Trop Dis"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1038\/s41598-018-22988-1","volume":"8","author":"MP Marinovic","year":"2018","unstructured":"Marinovic MP, Campeiro JD, Lima SC et al (2018) Crotamine induces browning of adipose tissue and increases energy expenditure in mice. Sci Rep 8:5057","journal-title":"Sci Rep"},{"key":"5_CR19","doi-asserted-by":"publisher","unstructured":"Campeiro JD, Dam W, Monte GG, Porta LC, Oliveira LCG, Nering MB, Viana GM, Carapeto FC, Oliveira EB, van den Born J, Hayashi MAF (2019). Long term safety of targeted internalization of cell penetrating peptide crotamine into renal proximal tubular epithelial cells in vivo. Sci Rep 9(1):3312. https:\/\/doi.org\/10.1038\/s41598-019-39842-7","DOI":"10.1038\/s41598-019-39842-7"},{"issue":"11","key":"5_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048913","volume":"7","author":"PC Chen","year":"2012","unstructured":"Chen PC, Hayashi MA, Oliveira EB et al (2012) DNA-interactive properties of crotamine, a cell-penetrating polypeptide and a potential drug carrier. PLoS One 7(11):e48913","journal-title":"PLoS One"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.bbagen.2006.09.011","volume":"1760","author":"HS Choi","year":"2006","unstructured":"Choi HS, Kim HH, Yang JM et al (2006) An insight into the gene delivery mechanism of the arginine peptide system: role of the peptide\/DNA complex size. Biochim Biophys Acta 1760:1604\u20131612","journal-title":"Biochim Biophys Acta"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.bbamem.2017.09.006","volume":"1859","author":"C Dal Mas","year":"2017","unstructured":"Dal Mas C, Pinheiro DA, Campeiro JD et al (2017) Biophysical and biological properties of small linear peptides derived from crotamine, a cationic antimicrobial\/antitumoral toxin with cell penetrating and, cargo delivery abilities. BBA-Biomembranes 1859:2340\u20132349","journal-title":"BBA-Biomembranes"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1021\/jp411886u","volume":"118","author":"BA Costa","year":"2014","unstructured":"Costa BA, Sanches L, Gomide AB et al (2014) Interaction of the rattlesnake toxin Crotamine with model membranes. J Phys Chem B 118:5471\u20135479","journal-title":"J Phys Chem B"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.toxicon.2015.11.021","volume":"116","author":"C Dal Mas","year":"2016","unstructured":"Dal Mas C, Moreira JT, Pinto S et al (2016) Anthelmintic effects of a cationic toxin from a south American rattlesnake venom. Toxicon 116:49\u201355","journal-title":"Toxicon"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.peptides.2016.01.013","volume":"78","author":"S Chamy Maluf El","year":"2016","unstructured":"El Chamy Maluf S, Dal Mas C, Oliveira EB et al (2016) Inhibition of malaria parasite Plasmodium falciparum development by crotamine, a cell penetrating peptide from the snake venom. Peptides 78:11\u201316","journal-title":"Peptides"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2017.12.013","volume":"163","author":"RL Karpel","year":"2018","unstructured":"Karpel RL, da Silva Liberato M, Campeiro JD et al (2018) Design and characterization of crotamine-functionalized gold nanoparticles. Colloids Surf B Biointerfaces 163:1\u20138","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00726-017-2513-3","volume":"50","author":"JD Campeiro","year":"2018","unstructured":"Campeiro JD, Marinovic MP, Carapeto FC et al (2018) Oral treatment with a rattlesnake native polypeptide crotamine efficiently inhibits the tumor growth with no potential toxicity for the host animal and with suggestive positive effects on animal metabolic profile. Amino Acids 50:267\u2013278","journal-title":"Amino Acids"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1055\/s-0038-1646066","volume":"58","author":"AR Giles","year":"1987","unstructured":"Giles AR (1987) Guidelines for the use of animals in biomedical research. Thromb Haemost 58:1078\u20131084","journal-title":"Thromb Haemost"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675","journal-title":"Nat Methods"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1590\/s1679-45082011ao2162","volume":"9","author":"K Scaramuzzi","year":"2011","unstructured":"Scaramuzzi K, Oliveira DCA, Carvalho LV et al (2011) Nanostructured SBA-15 silica as an adjuvant in immunizations with hepatitis B vaccine. Einstein 9:436\u2013441","journal-title":"Einstein"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1073\/pnas.1533186100","volume":"100","author":"Z Wu","year":"2003","unstructured":"Wu Z, Hoover DM, Yang D et al (2003) Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A 100:8880\u20138885","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1021\/ja0294257","volume":"125","author":"Z Wu","year":"2003","unstructured":"Wu Z, Powell R, Lu W (2003) Productive folding of human neutrophil \u03b2-defensins in vitro without the pro-peptide. J Am Chem Soc 125:2402\u20132403","journal-title":"J Am Chem Soc"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1021\/ac0702084","volume":"79","author":"W Haiss","year":"2007","unstructured":"Haiss W, Thanh NTK, Aveyard J et al (2007) Determination of size and concentration of gold nanoparticles from UV-vis spectra. Anal Chem 79:4215\u20134221","journal-title":"Anal Chem"},{"key":"5_CR34","first-page":"495","volume":"33","author":"J Chang","year":"2004","unstructured":"Chang J, Park YJ, Liang JF et al (2004) ATTEMPTS: a pharmaceutical engineering approach for delivery of macromolecular drugs. Front Biomed Eng 33:495\u2013506","journal-title":"Front Biomed Eng"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1016\/S0021-9258(19)41008-9","volume":"250","author":"ME Silva","year":"1975","unstructured":"Silva ME, Dietrich CP (1975) Structure of heparin. Characterization of the products formed from heparin by the action of a heparinase and a heparitinase from Flavobacterium heparinum. J Biol Chem 250:6841\u20136846","journal-title":"J Biol Chem"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1517\/13543784.2011.602064","volume":"20","author":"A Pereira","year":"2011","unstructured":"Pereira A, Kerkis A, Hayashi MA et al (2011) Crotamine toxicity and efficacy in mouse models of melanoma. Expert Opin Investig Drugs 20:1189\u20131200","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Methods in Molecular Biology","Nanoparticles in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0319-2_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T06:46:33Z","timestamp":1614753993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0319-2_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071603185","9781071603192"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0319-2_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"10 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}